A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1463-1326.2009.01059.xPMID 19740082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulin

  2004cited by this paper
• SF-36 health survey: Manual and interpretation guide

  2003cited by this paper
• Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.

  2003cited by this paper
• Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

  2003cited by this paper
• Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.

  2003cited by this paper
• Insulin pump therapy in patients with Type 1 diabetes mellitus: results of the Nationwide Quality Circle in Germany (ASD) 1999-2000.

  2003cited by this paper
• Quality of life of patients with type I diabetes mellitus

  2003cited by this paper
• Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

  2002cited by this paper
• Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

  2000cited by this paper
• Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association).

  1999cited by this paper
• Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

  1999cited by this paper
• How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes.

  1999cited by this paper
• Local Adverse Events Associated With Long-Term Treatment by Implantable Insulin Pumps: The French EVADIAC Study Group experience

  1998cited by this paper
• Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps

  1998cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.

  1998cited by this paper
• Long-Term Therapy of IDDM With an Implantable Insulin Pump

  1997cited by this paper
• Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.

  1997cited by this paper
• Insulin Lispro in CSII: Results of a Double-Blind Crossover Study

  1997cited by this paper
• Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.

  1996cited by this paper
• Insulin Underdelivery From Implanted Pumps Using Peritoneal Route: Determinant role of insulin pump compatibility

  1996cited by this paper
• Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.

  1996cited by this paper
• Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study

  1995cited by this paper
• Catheter Complications Associated With Implantable Systems for Peritoneal Insulin Delivery: An analysis of frequency, predisposing factors, and obstructing materials

  1995cited by this paper
• French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society.

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects.

  1993cited by this paper
• Randomized Comparison of Metabolic Control Achieved by Intraperitoneal Insulin Infusion With Implantable Pumps Versus Intensive Subcutaneous Insulin Therapy in Type I Diabetic Patients

  1992cited by this paper
• Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT)

  1988cited by this paper
• Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group.

  1988cited by this paper
• Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man

  1980cited by this paper

• Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature

  2025cites this paper
• Automated Insulin Delivery for Type 1 Diabetes: Present and Future.

  2025cites this paper
• Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial

  2023cites this paper
• Artificial Pancreas: In Silico Study Shows No Need of Meal Announcement and Improved Time in Range of Glucose With Intraperitoneal vs. Subcutaneous Insulin Delivery

  2021cites this paper
• A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules

  2021cites this paper
• Root cause determination of intraperitoneal catheter obstructions: Insulin amyloid aggregates vs foreign body reaction.

  2021cites this paper
• Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis

  2021influential citation
• Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence

  2021cites this paper
• A fully implantable device for diffuse insulin delivery at extraperitoneal site for physiological treatment of type 1 diabetes.

  2020cites this paper
• Treatment of type 1 diabetes complicated by problematic hypoglycemia

  2020cites this paper
• The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes

  2020cites this paper
• Oral insulin: an update.

  2020cites this paper
• Insulin-associated Weight Gain in Type 2 Diabetes and Its Relation with Caloric Intake

  2019cites this paper
• Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus

  2019cites this paper
• New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion

  2019cites this paper
• Use of intraperitoneal insulin delivery for artificial pancreas

  2019cites this paper
• A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance.

  2019cites this paper
• Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

  2019cites this paper
• PID-based Glucose Control using Intra-Peritoneal Insulin Infusion: An In Silico Study

  2019cites this paper
• Surgical options for glycaemic control in Type 1 diabetes

  2019cites this paper
• Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
.

  2018cites this paper
• Glucose Sensor Dynamics and the Artificial Pancreas: The Impact of Lag on Sensor Measurement and Controller Performance

  2018influential citation
• Risk analysis for the design of a safe artificial pancreas control system

  2018cites this paper
• Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?

  2018cites this paper
• Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology

  2018cites this paper
• Risk analysis for the design of a safe artificial pancreas control system

  2018cites this paper
• Controllability and observability of glucose insulin glucagon system in humans

  2018cites this paper
• Kontinuierliche intraperitoneale Insulininfusion

  2017influential citation
• Oral Insulin Delivery in a Physiologic Context: Review

  2017cites this paper
• Analysis of “A New Optimized Percutaneous Access System for CIPII”

  2017cites this paper
• A New Optimized Percutaneous Access System for CIPII

  2017cites this paper
• Glucose‐responsive insulin delivery for type 1 diabetes: The artificial pancreas story

  2017cites this paper
• Finding the right route for insulin delivery – an overview of implantable pump therapy

  2017influential citation
• Diabète de type1: pompeàinsuline

  2017cites this paper
• Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control‐based fully‐automated artificial pancreas in patients with type 1 diabetes: a pilot study

  2017cites this paper
• Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.

  2017cites this paper
• Kurzwirksame Insuline — Neuentwicklungen hin zu mehr Flexibilität für den Patienten

  2016cites this paper
• Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement

  2016cites this paper
• [Fast-acting insulin - new developments towards more flexibility for the patient].

  2016cites this paper
• Impact of Sensing and Actuation Characteristics on Artificial Pancreas Design

  2016cites this paper
• The Artificial Pancreas: A Dynamic Challenge

  2016cites this paper
• 9th Annual Symposium on Self-Monitoring of Blood Glucose, April 28–30, 2016, Madrid, Spain

  2016cites this paper
• Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes

  2015cites this paper
• Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment

  2015cites this paper
• Continuous Intraperitoneal Insulin Infusion from Implantable Pumps

  2015cites this paper
• Beta-Zell-Ersatztherapie

  2015cites this paper
• Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease

  2015cites this paper
• Running title: Peripheral Insulin Delivery and Hypoglycemia

  2015cites this paper
• Neue Technologien in der Diabetologie

  2015cites this paper
• Too Much or Too Little? The Double Jeopardy of Subcutaneous Insulin Therapy in Diabetes

  2015cites this paper
• Continuous intraperitoneal insulin infusion in the treatment of type 1 diabetes mellitus

  2015cites this paper
• Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas

  2015cites this paper
• Implantable insulin pumps: an effective option with restricted dissemination.

  2014cites this paper
• Auf dem Weg zum „Closed-loop“-System

  2014cites this paper
• Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia

  2014cites this paper
• Changes in Glucose and Fat Metabolism in Response to the Administration of a Hepato-Preferential Insulin Analog

  2014cites this paper
• Bio-Inspired Glucose Control in Diabetes Based on an Analogue Implementation of a $\beta $-Cell Model

  2014cites this paper
• The Artificial Pancreas

  2014cites this paper
• 6th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, April 25–27, 2013, Riga, Latvia

  2013cites this paper
• Potential role of non‐insulin adjunct therapy in Type 1 diabetes

  2013cites this paper
• A review of artificial pancreas technologies with an emphasis on bi‐hormonal therapy

  2013cites this paper
• The impact of insulin pharmacokinetics and pharmacodynamics on the closed-loop artificial pancreas

  2013cites this paper
• Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port.

  2013cites this paper
• Closer to ideal insulin action: ultra fast acting insulins.

  2013cites this paper
• Closed-loop insulin delivery: towards improved diabetes care.

  2012cites this paper
• Closed-loop insulin delivery in adults with type 1 diabetes

  2012cites this paper
• The Artificial Pancreas

  2012cites this paper
• In search of improved glucose control: helping the patient decide between insulin injections and infusion pump therapy

  2012cites this paper
• Innovative Treatments in Diabetes Type 1

  2012cites this paper
• 5th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 3–5, 2012, Dublin, Ireland

  2012cites this paper
• Evolution of Devices in Diabetes Management

  2011cites this paper
• Closed-loop insulin delivery: from bench to clinical practice

  2011cites this paper
• Clinical Hurdles and Possible Solutions in the Implementation of Closed-Loop Control in Type 1 Diabetes Mellitus

  2011cites this paper
• Pharmacodynamic Evaluation: Diabetes Methodologies

  2011cites this paper
• Closed-loop insulin delivery for treatment of type 1 diabetes

  2011cites this paper
• Current literature in diabetes

  2010cites this paper
• Lösungsansätze bei frustraner Insulinpumpentherapie

  2009cites this paper
• Intraperitoneal insulin infusion : on the way to the artificial pancreas

  year unknowncites this paper